Admission Date:  [**2122-9-22**]     Discharge Date:  [**2122-10-10**]

Date of Birth:   [**2063-8-30**]     Sex:  F

Service:  O-Med

ADDENDUM:  Patient's course since [**2122-10-7**]:  The patient
returned to the O-Med service on [**10-7**].  The patient's white
blood cell count rose to within normal limits on [**10-8**].  She
required transfusion of one unit of platelets.  Her
hematocrit at that time was stable.  Her SMA 10 at that time
was also stable.  The whole brain XRT was continued.  The
Decadron was decreased to 4 mg [**Hospital1 **].  The patient's CBC was
checked again later that evening and the white blood cell
count continued to rise.  Therefore, the GCSF and the
Ceftazidime were discontinued at that time.  The patient
continued to receive Respalor tube feeds for nutrition.  On
[**10-9**] the patient continued to do well and improve.  She
maintained her oxygenation as noted previously.  Her CBC
remained within normal limits, a change from prior.  She
continued to receive her whole brain XRT.  She was screened
for acute rehab and was approved for [**Hospital1 **] Acute Rehab.
The patient's pain was controlled with a Fentanyl patch and
Percocet prn rescue.  The patient continued to have some
secretions but with physical therapy, chest PT and vigorous
coughing, the patient continued to mobilize and did not mucus
plug or have any more shortness of breath.

DISCHARGE MEDICATIONS:  Zantac 150 mg po bid as needed,
Fentanyl patch 25 mcg per hour, change every three days,
Synthroid 40 mcg po q d, Heparin 5,000 units subcu [**Hospital1 **],
Demeclocycline 300 mg po q d, Buspar 5 mg po q d, Decadron 4
mg [**Hospital1 **], tube feedings, Respalor at 35 cc per hour.
Additional prn medicines include Albuterol and Atrovent MDI,
Ativan .5 mg po q 8 hours prn, Desitin cream to buttock rash
and Percocet 1-2 tablets po q 4-6 hours as needed for rescue.
 The patient was discharged in stable condition on [**2122-10-10**] to
[**Hospital **] Rehab.

DISCHARGE DIAGNOSIS:
1.  Metastatic lung cancer.
2.  Pneumonia.
3.  Chronic obstructive pulmonary disease.
4.  SIADH.
5.  Hypothyroidism.
6.  Anxiety.




                          [**First Name11 (Name Pattern1) 177**] [**Last Name (NamePattern4) 178**], M.D.  [**MD Number(1) 179**]

Dictated By:[**Last Name (NamePattern1) 8228**]

MEDQUIST36

D:  [**2122-10-9**]  16:25
T:  [**2122-10-9**]  16:35
JOB#:  [**Job Number 35858**]

cc:[**Hospital1 35859**]